Observational study shows effective treatments for carbapenem-resistant infections in India, suggesting urgent access to new antibiotics.
Our study showed an exceptionally high prevalence of the blaNDM gene among CRE clinical isolates. Either aztreonam-avibactam or cefiderocol was found to be effective against 98% of CRE isolates highlighting the immediate need of making these two drugs accessible to patients in India.
No takes yet. Share an insight, caveat, or question.
Sengupta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: